Clinical Trials Browser

Phase 1 × samarium Sm-153 lexidronam × Plasma cell × Clear all

NCT00316940 2013-09-20

Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 1 Completed

Multiple Myeloma, Neoplasms, Plasma Cell